ArticleJournal of gynecology obstetrics and human reproduction2026
The association between maternal HIV and stillbirths in an Era of universal ART access in pregnancy in the Western Cape, South Africa, 2017 - 2021.
Article in Journal of gynecology obstetrics and human reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMaternal HIV infection has been associated with adverse pregnancy outcomes, including stillbirth. We aimed to investigate the association between maternal HIV and stillbirths in the context of universal antiretroviral therapy (ART) during pregnancy in the Western Cape, South Africa.
methodsWe defined a cohort of pregnant women with documented HIV status and pregnancy outcome >20 weeks gestation enrolled in the Western Cape Pregnancy Exposure Registry from January 2017 - December 2021. Descriptive statistics and logistic regression analyses assessed proportion of stillbirths and odds ratios by HIV and ART status, and their relationship with clinical and demographic variables.
resultsAmong 15,123 pregnant women, HIV prevalence was 31.6 % at pregnancy outcome (n = 4773) and 61.6 % of women living with HIV (WLHIV) had started ART prior to pregnancy. Although stillbirths were higher among WLHIV: 17/1000 births (95 %CI:13.3-20.7; n = 79) versus 14/1000 births (95 % CI:11.8-16.3; n = 147) among women without HIV, HIV was not associated with stillbirth in multivariable analysis (aOR=1.2, 95 % CI:0.9-1.5). Among WLHIV, ART duration ART≥100weeks had reduced odds of stillbirth compared to those on ART<20weeks (aOR=0.5, 95 % CI: 0.3-0.9). Pre-existing diabetes was associated with stillbirth (aOR=2.6, 95 % CI: 1.1-6.5).
conclusionIn this cohort of pregnant women we found no differences in stillbirth rates between WLHIV and women without HIV but given the sample size and number of stillbirths, the study could not exclude small increases in risk. Longer ART duration was confirmed to be protective for stillbirth among WLHIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.